ExeVir Bio

ExeVir Bio

Foundation date

10/07/2020

Sector

#Biotechnology - Therapeutics

Subsector

• #Therapeutics - Antibodies

Therapeutic areas

• #Infectious and parasitic diseases

ExeVir Bio is a clinical stage company harnessing its VHH technology platform to generate robust antiviral therapies providing broad protection against viral infections, including pan-coronaviruses. It is a spin out from VIB, the world class Belgium-based life sciences research institute. ExeVir’s platform is based on the work of and collaboration with Professor Dr. Xavier Saelens and Professor Dr. Nico Callewaert from VIB.